Therefore, the objective of our current study was to search for new targets, which might help developing effective therapeutic strategies against cancers harboring aberrant ras. Using the ras loop mutant constructs, we demonstrated that PI3K/Akt signaling appeared functioning downstream of mutant Ras and was able to activate cell death program after the co-suppression of PKC α and β. The gene discussed is PRRT2; the disease is cancer.